Fuso Pharmaceutical Industries Ltd.

Publication No. WO/2009/107775 Published on Sept. 3, Assigned to National University, Fuso Pharmaceutical Industries for Expression Vector (Japanese, American Inventors)
US Fed News Service, Including US State News; 9/10/2009; 438 words; ...The patent has been assigned to National University Corp. Hokkaido University, Hokkaido, Japan, and Fuso Pharmaceutical Industries Ltd., Osaka, Japan. According to an abstract posted by the World Intellectual Property Organization, the...

Patent No.7,572,890 Issued on Aug. 11, Assigned to Fuso Pharmaceutical Industries for Recombinant Human Mannan-Building Proteins (Japanese Inventor)
US Fed News Service, Including US State News; 8/14/2009; 386 words; ...The inventor was issued U.S. Patent No. 7,572,890 on Aug. 11. The patent has been assigned to Fuso Pharmaceutical Industries Ltd., Osaka, Japan. According to the abstract released by the U.S. Patent & Trademark Office...

Patent No. 7,563,594 Assigned to Fuso Pharmaceutical Industries for Cytolethal Distending Toxins and Detection of Campylobacter Bacteria Using the Came as Target on July 21 (Japanese Inventors)
US Fed News Service, Including US State News; 7/24/2009; 431 words; ...target. The inventors were issued Patent No. 7,563,594 on July 21. The patent has been assigned to Fuso Pharmaceutical Industries Ltd., Osaka. According to the abstract released by the U.S. Patent & Trademark Office: "The present...

JAPANESE BIOVENTURE ON TRACK WITH PANCREATIC CANCER VACCINE.
AsiaPulse News; 6/24/2009; 624 words; ...the market sometime in or after 2011. Oncotherapy Science licensed exclusive domestic marketing rights to Fuso Pharmaceutical Industries Ltd. (TSE:4538) in 2005. (Nikkei) sld 24-06 1556

JAPAN'S FUSO READYING ORAL VERSION OF DRUG FOR POST-SHINGLE PAIN.
AsiaPulse News; 6/10/2009; 871 words; TOKYO, June 10 Asia Pulse - Fuso Pharmaceutical Industries Ltd. (TSE:4538) is finishing...course of six to eight hours. Fuso Pharmaceutical estimates that...Pharmaceutical Co. sells. After Fuso begins marketing the drug for...